Immutopics, Inc. was acquired by Diagnostic Hybrids, Inc., a wholly owned subsidiary of Quidel Corporation, on March 18, 2016. Quidel is excited to have Immutopics join the Quidel family and portfolio of products and believes the combination of the Immutopics portfolio with Quidel's MicroVueTM products will enhance our ability to serve the bone health research community. Please see About Us for additional information.

Human BioActive PTH (1-84) ELISA kit

For the Quantitative Determination of Human Bioactive Intact PTH Levels in Plasma or Cell Culture Media.
Description Item # (µL) Incubation Time Sensitivity Type
ELISA kit 60-3000 50 3 hr + 30 min 96 well microplate